Modular Medical, Inc. — Income Charts
52 quarters of history · ending 2022-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-14775.0% -$591
$-587
Cost of Revenue
$0
Gross Profit
$0
R&D↑+18.8% +$348K
$2M
D&A↑+23.1% +$6K
$33K
Operating Income↑+12.3% +$473K
$-3M
EBITDA↑+12.6% +$479K
$-3M
Interest Expense
$547K
Interest Income
$22
Other Income/Expense↓-100.0% -$4
$0
Pretax Income↑+30.6% +$1M
$-3M
Tax Provision
$0
Net Income↑+30.6% +$1M
$-3M
Gross Margin
0.0%
Operating Margin↑+96348661.3pts
572061.3%
Net Margin↑+121604736.3pts
572061.3%
Effective Tax Rate↑+0.0pts
0.0%
Deferred Tax Assets
$0
DTA Valuation Allowance↑+121.6% +$5M
$10M
NOL Carryforwards↑+114.3% +$4M
$7M
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+0.0pts
-7.0%
ETR Foreign Differential (pp)
—
Operating Lease CostNEW↑+0.0% +$0
$27K
Revenue YoY Variation↓-14693.2pts
-14775.0%
Income YoY Variation↑+117.2pts
12.3%
Revenue QoQ Variation↓-201.4pts
-293.1%
Income QoQ Variation↑+6.3pts
2.6%
Modular Medical, Inc. — Customer & Supplier ConcentrationNEW
Major-customer and supplier-side disclosures sourced from srt:MajorCustomersAxis dimensional XBRL. Coverage is ~44% of the S&P 500 (sparser than other panels) but high-value when present — a 20%+ single-counterparty exposure is a headline business risk required to be disclosed in 10-K MD&A under Reg S-K Item 101.
Supplier-Side Concentration
Input dependence on a single vendor / supplier (AAPL Vendor 1 = 46% is the canonical disclosure on this side).
As of 2025-03-31 · 1 row
| Counterparty | Kind | Concentration | Revenue / Spend |
|---|---|---|---|
| Vendor | vendor | 10.0% | — |